Galectin 3 Induces a Distinctive Pattern of Cytokine and Chemokine Production in Rheumatoid Synovial Fibroblasts via Selective Signaling Pathways

被引:146
作者
Filer, Andrew [1 ]
Bik, Magdalena
Parsonage, Greg N.
Fitton, John
Trebilcock, Emily
Howlett, Katherine
Cook, Michelle
Raza, Karim
Simmons, David L. [2 ]
Thomas, Andrew M. C. [3 ]
Salmon, Mike
Scheel-Toellner, Dagmar
Lord, Janet M.
Rabinovich, Gabriel A. [4 ]
Buckley, Christopher D.
机构
[1] Univ Birmingham, Div Immun & Infect, Birmingham B15 2TT, W Midlands, England
[2] Cellzome, Cambridge, England
[3] Royal Orthopaed Hosp, NHS Fdn Trust, Birmingham B31 2AP, W Midlands, England
[4] Consejo Nacl Invest Cient & Tecn, IBYME, RA-1033 Buenos Aires, DF, Argentina
来源
ARTHRITIS AND RHEUMATISM | 2009年 / 60卷 / 06期
基金
英国医学研究理事会;
关键词
N-TERMINAL KINASE; MONOCYTE CHEMOATTRACTANT PROTEIN-1; BINDING-PROTEIN; T-CELLS; GLYCAN INTERACTIONS; IMMUNE-RESPONSE; ARTHRITIS; EXPRESSION; SYNOVIOCYTES; NEUTROPHILS;
D O I
10.1002/art.24574
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective. High expression of galectin 3 at sites of joint destruction in rheumatoid arthritis (RA) suggests that galectin 3 plays a role in RA pathogenesis. Previous studies have demonstrated the effects of galectins on immune cells, such as lymphocytes and macrophages. This study was undertaken to investigate the hypothesis that galectin 3 induces proinflammatory effects in RA by modulating the pattern of cytokine and chemokine production in synovial fibroblasts. Methods. Matched samples of RA synovial and skin fibroblasts were pretreated with galectin 3 or tumor necrosis factor alpha (TNF alpha), and the levels of a panel of cytokines, chemokines, and matrix metalloproteinases (MMPs) were determined using enzyme-linked immunosorbent assays and multiplex assays. Specific inhibitors were used to dissect signaling pathways, which were confirmed by Western blotting and NF-kappa B activation assay. Results. Galectin 3 induced secretion of interleukin-6 (IL-6), granulocyte-macrophage colony-stimulating factor, CXCL8, and MMP-3 in both synovial and skin fibroblasts. By contrast, galectin 3-induced secretion of TNF alpha, CCL2, CCL3, and CCL5 was significantly greater in synovial fibroblasts than in skin fibroblasts. TNF alpha blockade ruled out autocrine TNF alpha-stimulated induction of chemokines. The MAPKs p38, JNK, and ERK were necessary for IL-6 production, but phosphatidylinositol 3-kinase (PI 3-kinase) was required for selective CCL5 induction. NF-kappa B activation was required for production of both IL-6 and CCL5. Conclusion. Our findings indicate that galectin 3 promotes proinflammatory cytokine secretion by tissue fibroblasts. However, galectin 3 induces the production of mononuclear cell-recruiting chemokines uniquely from synovial fibroblasts, but not matched skin fibroblasts, via a PI 3-kinase signaling pathway. These data provide further evidence of the role of synovial fibroblasts in regulating the pattern and persistence of the inflammatory infiltrate in RA and suggest a new and important functional consequence of the observed high expression of galectin 3 in the rheumatoid synovium.
引用
收藏
页码:1604 / 1614
页数:11
相关论文
共 60 条
[1]   Targeted disruption of the galectin-3 gene results in decreased susceptibility to NNK-induced lung tumorigenesis: an oligonucleotide microarray study [J].
Abdel-Aziz, Hekmat Osman ;
Murai, Yoshihiro ;
Takasaki, Ichiro ;
Tabuchi, Yoshiaki ;
Zheng, Hua-chuan ;
Nomoto, Kazuhiro ;
Takahashi, Hiroyuki ;
Tsuneyama, Koichi ;
Kato, Ichiro ;
Hsu, Daniel K. ;
Liu, Fu-tong ;
Hiraga, Koichi ;
Takano, Yasuo .
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2008, 134 (07) :777-788
[2]   Interleukin-18 induces angiogenic factors in rheumatoid arthritis synovial tissue fibroblasts via distinct signaling pathways [J].
Amin, Mohammad A. ;
Mansfield, Pamela J. ;
Pakozdi, Angela ;
Campbell, Phillip L. ;
Ahmed, Salahuddin ;
Martinez, Rita J. ;
Koch, Alisa E. .
ARTHRITIS AND RHEUMATISM, 2007, 56 (06) :1787-1797
[3]   TWEAK/Fn14 interaction regulates RANTES production, BMP-2-induced differentiation, and RANKL expression in mouse osteoblastic MC3T3-E1 cells [J].
Ando, Takashi ;
Ichikawa, Jiro ;
Wako, Masanori ;
Hatsushika, Kyosuke ;
Watanabe, Yoshiyuki ;
Sakuma, Michitomo ;
Tasaka, Kachio ;
Ogawa, Hideoki ;
Hamada, Yoshiki ;
Yagita, Hideo ;
Nakao, Atsuhito .
ARTHRITIS RESEARCH & THERAPY, 2006, 8 (05)
[4]  
ARNETT FC, 1987, ARTHRITIS RHEUM, V31, P315
[5]   Impact of protein-glycan interactions in the regulation of autoimmunity and chronic inflammation [J].
Bianco, German A. ;
Toscano, Marta A. ;
Ilarregui, Juan M. ;
Rabinovich, Gabriel A. .
AUTOIMMUNITY REVIEWS, 2006, 5 (05) :349-356
[6]   Fibroblasts regulate the switch from acute resolving to chronic persistent inflammation [J].
Buckley, CD ;
Pilling, D ;
Lord, JM ;
Akbar, AN ;
Scheel-Toellner, D ;
Salmon, M .
TRENDS IN IMMUNOLOGY, 2001, 22 (04) :199-204
[7]   Fibroblast-like synoviocytes support B-cell pseudoemperipolesis via a stromal cell-derived factor-1-and CD106 (VCAM-1)-dependent mechanism [J].
Burger, JA ;
Zvaifler, NJ ;
Tsukada, N ;
Firestein, GS ;
Kipps, TJ .
JOURNAL OF CLINICAL INVESTIGATION, 2001, 107 (03) :305-315
[8]   A novel spleen tyrosine kinase inhibitor blocks c-jun N-terminal kinase-mediated gene expression in synoviocytes [J].
Cha, HS ;
Boyle, DL ;
Inoue, T ;
Schoot, R ;
Tak, PP ;
Pine, P ;
Firestein, GS .
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2006, 317 (02) :571-578
[9]   Mediation of the proinflammatory cytokine response in rheumatoid arthritis and spondylarthritis by interactions between fibroblast-like synoviocytes and natural killer cells [J].
Chan, Antoni ;
Filer, Andrew ;
Parsonage, Greg ;
Kollnberger, Simon ;
Gundle, Roger ;
Buckley, Christopher D. ;
Bowness, Paul .
ARTHRITIS AND RHEUMATISM, 2008, 58 (03) :707-717
[10]   Role of galectin-3 in mast cell functions: Galectin-3-deficient mast cells exhibit impaired mediator release and defective JNK expression [J].
Chen, Huan-Yuan ;
Sharma, Bhavya B. ;
Yu, Lan ;
Zuberi, Riaz ;
Weng, I-Chun ;
Kawakami, Yuko ;
Kawakami, Toshiaki ;
Hsu, Daniel K. ;
Liu, Fu-Tong .
JOURNAL OF IMMUNOLOGY, 2006, 177 (08) :4991-4997